Clinical Studies

Adjustment of Insulin Pump Settings in Type 1 Diabetes Management: Advisor Pro Device Compared to Physicians’ Recommendations

Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes

Decision Support Systems for Insulin Treatment Adjustment in People with Type 1 Diabetes.

Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial.

DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.

Adjusting insulin doses in patients with type 1 diabetes that use insulin pump and continuous glucose monitoring ‐ Variations among countries and physicians

Reduced Worries of Hypoglycemia, High Satisfaction, and Increased Perceived Ease of Use after Experiencing Four Nights of MD-Logic Artificial Pancreas at Home (DREAM4).

MD-Logic Overnight Control for 6 Weeks of Home Use in Patients With Type 1 Diabetes: Randomized Crossover Trial

Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial—interim analysis

The “Glucositter” overnight automated closed loop system for type 1 diabetes: A randomized crossover trial

Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp

Feasibility Study of Automated Overnight Closed-Loop Glucose Control Under MD-Logic Artificial Pancreas in Patients with Type 1 Diabetes: The DREAM Project

MD-Logic Artificial Pancreas System: A pilot study in adults with type 1 diabetes